You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Human T-Cell Lymphotropic Virus (HTLV1)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Evaluation of Patients With HAM/TSP

Recruiting
  • HTLV-I Infection
  • Tropical Spastic Paraparesis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Survival of Adult T-cell Leukemia / Lymphoma and Patients

    Recruiting
    • Lymphoproliferation Induced by HTLV-1
    • +2 more
      • Paris, France
        Hôpital Necker Enfants Malades
      Sep 26, 2022

      HTLV-I Infection Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Raltegravir)

      Completed
      • HTLV-I Infection
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 18, 2022

      Human T-Lymphotropic Virus Type 1 Associated Myelopathy Trial in Belém (Inspiratory muscle trainning, Exercise)

      Recruiting
      • Human T-Lymphotropic Virus Type 1 Associated Myelopathy
      • Inspiratory muscle trainning
      • Exercise
      • Belém, Pará, Brazil
        Universidade do Estado do Pará
      Apr 30, 2021

      Normal Subjects and Disorders of Immune System and Cancer

      Recruiting
      • T-cell Lymphoma
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 24, 2023

        HTLV-I Infections Trial in Belém (Rehabilitation)

        Completed
        • HTLV-I Infections
        • Rehabilitation
        • Belém, Pará, Brazil
          Universidade da Amazônia
        Aug 11, 2020

        Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Classical Hodgkin Lymphoma Trial in Houston (CD30.CAR-EBVST cells)

        Recruiting
        • Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
        • Classical Hodgkin Lymphoma
        • CD30.CAR-EBVST cells
        • Houston, Texas
        • +1 more
        Jul 20, 2022

        Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

        Recruiting
        • Acute Adult T-Cell Leukemia/Lymphoma
        • +3 more
        • Atlanta, Georgia
        • +13 more
        Jan 26, 2023

        Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

        Completed
        Has Results
        • Adult T-Cell Lymphoma/Leukemia
        • +2 more
        • Recombinant human Interleukin-15 (rhIL-15)
        • Mogamulizumab
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 9, 2022

        Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,

        Not yet recruiting
        • Head and Neck Cancer
        • +20 more
        • TSC-204-A0201
        • +4 more
        • Scottsdale, Arizona
        • +1 more
        Aug 3, 2023

        Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)

        Not yet recruiting
        • Oropharyngeal Cancer
        • +10 more
        • (no location specified)
        Dec 14, 2022

        Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)

        Not yet recruiting
        • Soft Tissue Sarcoma
        • Bone Sarcoma
        • Houston, Texas
          M D Anderson Cancer Center
        Nov 10, 2022

        Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

        Recruiting
        • Myelodysplastic Syndrome
        • +16 more
        • Computed Tomography
        • +6 more
        • Scottsdale, Arizona
        • +2 more
        Feb 3, 2022

        B-cell Acute Lymphoblastic Leukemia Trial in Nanchang (Human CD19 Targeted DASH CAR-T Cells Injection)

        Recruiting
        • B-cell Acute Lymphoblastic Leukemia
        • Human CD19 Targeted DASH CAR-T Cells Injection
        • Nanchang, Jiangxi, China
          The Second Affiliated Hospital of Nanchang University
        Dec 13, 2022

        Advanced Malignancies Trial in Beijing (1A46 Drug Substance)

        Not yet recruiting
        • Advanced Malignancies
        • 1A46 Drug Substance
        • Beijing, Beijing, China
          Beijing Cancer Hospital
        Aug 4, 2023

        Lymphoma, Non-Hodgkin Trial (JNJ-87801493, JNJ-80948543, JNJ-75348780)

        Not yet recruiting
        • Lymphoma, Non-Hodgkin
        • (no location specified)
        Nov 15, 2023

        Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

        Recruiting
        • Acute Myeloid Leukemia
        • +4 more
        • Recombinant Interleukin-7
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 26, 2023

        Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United

        Recruiting
        • Folliculotropic Mycosis Fungoides
        • +7 more
        • Durvalumab
        • +2 more
        • Duarte, California
        • +3 more
        Jan 12, 2023

        Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

        Not yet recruiting
        • Multiple Sclerosis
        • +2 more
        • KYV-101 anti-CD19 CAR-T cell therapy
        • Standard lymphodepletion regimen
        • Palo Alto, California
          Stanford Multiple Sclerosis Center
        Nov 13, 2023

        CNS Lymphoma Trial in Nanchang (Human CD19-CD22 Targeted T Cells Injection)

        Recruiting
        • Central Nervous System Lymphoma
        • Human CD19-CD22 Targeted T Cells Injection
        • Nanchang, Jiangxi, China
          The Second Affiliated Hospital of Nanchang University
        Dec 13, 2022

        Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,

        Recruiting
        • Lupus Nephritis
        • +2 more
        • KYV-101 anti-CD19 CAR-T cell therapy
        • Standard lymphodepletion regimen
        • Denver, Colorado
        • +1 more
        Jul 7, 2023

        Colorectal Cancer Trial in Stockholm, Västerås (pTTL)

        Recruiting
        • Colorectal Cancer
        • Stockholm, Sweden
        • +1 more
        Jun 7, 2023

        Respiratory Syncytial Virus Infections, Influenza, Human Trial in London (RSV A Memphis 37, Influenza A/California/04/2009)

        Terminated
        • Respiratory Syncytial Virus Infections
        • Influenza, Human
        • RSV A Memphis 37
        • Influenza A/California/04/2009
        • London, United Kingdom
          National Heart and Lung Institute, Imperial College London
        Jun 23, 2022

        Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

        Recruiting
        • Hodgkin Disease
        • +5 more
        • MABEL CTLs
        • +2 more
        • Houston, Texas
        • +1 more
        Jan 13, 2023

        Extranodal NK/T Cell Lymphoma, Nasal Type Trial in Guangdong (IBI318(Recombinant human anti-PD1/PD-L1 bispecific antibody))

        Active, not recruiting
        • Extranodal NK/T Cell Lymphoma, Nasal Type
        • IBI318(Recombinant human anti-PD1/PD-L1 bispecific antibody)
        • Guangdong, China
          Sun Yat-sen University Cancer Center
        Oct 10, 2022